Abstract:There is increasing data showing that angiotensin (Ang) II may be involve in the initiation and regulation of processes occurring in brain ischemia. Microvascular changes in the brain are notably the cause of cerebral edema and ischemia injury. we have recently shown Ang II injuries brain microvascular endothelial cells (BMECs) partly via regulation of intercellular adhesion molecule-1 (ICAM-1) expression. However, the signaling cascade leading to Ang II-induced ICAM-1 expression in BMECs had not been well elucidated. The transcription factor, nuclear factor-κB (NF-κB) is involved in the expression of several proinflammatory genes including cell adhesion molecules. The aim of the present study was to investigate the possible mechanism of Ang II regulating the expression of ICAM-1 in BMECs and evaluated the effect of a novel selective AT1 receptor antagonist EXP-2528. Cultured BCMECs were incubated with Ang II (10-7 mol/L) with or without the specific AT1 receptor inhibitor losartan (10-6 mol/L) and EXP-2528 (10-6 mol/L) and the specific AT2 receptor inhibitor PD 123,319 (10-6 mol/L) for indicated times. Total RNA, cytoplasmic and nuclear protein were extracted from different groups of cultured BMECs. RT-PCR was used to assess ICAM-1 mRNA expression, western blot analysis was used to assess ICAM-1 and IκBα protein expression. Nuclear extracts were used for western blot analysis of p65 protein expression and for electrophoretic mobility shift assay of NF-κB activity. Ang II directly stimulates ICAM-1 mRNA and protein expression in BMECs. Ang II treatment also resulted in the degradation of IκBα, an evident increasing of p65 subunit expression in the nucleus as well as the nuclear translocation of NF-κB. These effects were abolished by preincubation with the AT1-specific antagonist losartan or EXP-2528 or losartan plus the AT2 receptor antagonist PD123319 but not by PD123319 alone. Moreover, there were no significant difference between losartan group and losartan + PD 123,319 group. The present study demonstrates that Ang II upregulated ICAM-1 expression via NF-κB activation in BMECs by activating AT1 receptor, AT1 receptor antagonists, both EXP-2528 and losartan inhibit such effect of Ang II.

Angiotensin II-induced Upregulation of AT(1) Receptor Expression: Sequential Activation of NF-kappaB and Elk-1 in Neurons.

Angiotensin II Induces Upregulation of AT1 Receptors Via the Sequential Activation of Transcription Factors NFkB, Elk‐1 and AP‐1 in Cath.a Cells

Angiotensin II Induces AT1 Receptor Upregulation by Oxidative Stress and Activation of AP1 and NF‐κB in Two Neuronal Cell Lines

Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Anti‐inflammatory Action of Angiotensin‐(1–7) and the Angiotensin Type 2 Receptor Agonist Compound 21 in Hypothalamic Microglia

EXP-2528, a Novel Angiotensin II Type 1 Receptor Antagonist, Protects Angiotensin II-stimulated Intercellular Adhesion Molecule-1 Via Nuclear Factor-Κb Activation in Brain Microvascular Endothelial Cells

Neuronal Angiotensin Ii Type 1 Receptor Upregulation In Heart Failure - Activation Of Activator Protein 1 And Jun N-Terminal Kinase

Role Of Oxidant Stress On At1 Receptor Expression In Neurons Of Rabbits With Heart Failure And In Cultured Neurons

Abstract 1380: Antioxidants Decrease Neuronal Angiotensin II Type 1 Receptor in Heart Failure: Inhibition of Activator Protein 1 and Jun N-Terminal Kinase

Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages

Angiotensin-(1-7) Increases Neuronal Potassium Current Via A Nitric Oxide-Dependent Mechanism

Angiotensin II stimulates intercellular adhesion molecule-1 via an AT 1 receptor/nuclear factor-κB pathway in brain microvascular endothelial cells

Neuronal Angiotensin II Type 1 Receptor Upregulation in Heart Failure

Expression of angiotensin II type 1 (AT(1)) receptor in the rostral ventrolateral medulla in rats.

Angiotensin II enhances hyperpolarization-activated currents in rat aortic baroreceptor neurons: involvement of superoxide.

Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats

Angiotensin II up-regulates expression of inducible nitric oxide synthase in human umbilical endothelial cells: roles of AT1 and AT2]

Angiotensin II represses Npr1 expression and receptor function by recruitment of transcription factors CREB and HSF-4a and activation of HDACs

ROS and Endothelial Nitric Oxide Synthase (Enos)-Dependent Trafficking of Angiotensin II Type 2 Receptor Begets Neuronal NOS in Cardiac Myocytes.

Abstract 501: Angiotensin II Increases Angiogenesis by Nf-κB-mediated Transcriptional Activation of Angiogenic Factor Aggf1